Recent engineering probes into the July 2026 buckling of load-bearing columns at the former Pfizer headquarters during its Manhattan office-to-residential conversion form the main driver behind the market's near-even odds. Investigators are examining whether design flaws, construction shortcuts, or material issues triggered the failure, with outcomes that could support criminal negligence findings or remain limited to civil and regulatory actions. The closely balanced trader consensus reflects uncertainty over how quickly forensic reports will emerge and whether any evidence meets the threshold for charges by year-end. Key variables that could shift probabilities include the release of detailed inspection findings, involvement by district attorneys or federal agencies, or confirmation that standard oversight lapses occurred without intent.